reports
- Jonathan Moreland
TRS TRIMAS CORPORATION
TLYS TILLYS
TCBI TEXAS CAPITAL BANCSHARES INC.
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
MTH MERITAGE HOMES CORPORATION
INUV INUVO INC
FFIN FIRST FINANCIAL BANKSHARES INC
CAL CALERES INC.
CABO CABLE ONE INC.
PATK PATRICK INDUSTRIES INC.
ADC AGREE REALTY CORPORATION
TTI TETRA TECHNOLOGIES INC.
UEIC UNIVERSAL ELECTRONICS INC.
VRA VERA BRADLEY INC.
CIA CITIZENS INC. CL A
CC CHEMOURS CO.
IOVA IOVANCE BIOTHERAPEUTICS INC
QTRX QUANTERIX CORPORATION
RSSS RESEARCH SOLUTIONS
BHC BAUSCH HEALTH COMPANIES INC.
BBDC BARINGS BDC INC.
YMAB Y-MABS THERAPEUTICS
ETON ETON PHARMACEUTICALS
IMUX IMMUNIC INC
BLDR BUILDERS FIRSTSOURCE
FNWB INC.
AMPY FIRST NORTHWEST BANCORP
DCTH AMPLIFY ENERGY
ENX DELCATH SYSTEMS
TSHA EATON VANCE NEW YORK MUNICIPAL BOND FUND
SMMT TAYSHA GENE THERAPIES
HLMN SUMMIT THERAPEUTICS INC
COOK HILLMAN SOLUTIONS CORP.
AIRS TRAEGER
GECC INC.
TYRA AIRSCULPT TECHNOLOGIES INC
NNUP GREAT ELM CAPITAL CORP
BHRB TYRA BIOSCIENCES INC
DPG NOCOPI TECHS INC
RNXT BURKE & HERBERT BANK & TR/VA
GTE DUFF & PHELPS GLOBAL UTIL INCOME FD
SRBK RENOVORX INC
NKGN GRAN TIERRA ENERGY INC.
MNR SR BANCORP INC
NBBK NKGEN BIOTECH INC
NCDL MACH NATURAL RESOURCES LP
SDHY NB BANCORP INC.
ABL NUVEEN CHURCHILL DIRECT LENDING CORP
WHLR PGIM SHORT DURATION HIGH YIELD OPPORTUNITIES FUND
ABACUS GLOBAL MANAGEMENT INC.
WHEELER REAL ESTATE INVESTMENT TRUST INC.
- Jonathan Moreland
WSR WHITESTONE REIT
TTSH TILE SHOP HOLDINGS INC.
TRS TRIMAS CORPORATION
TLYS TILLYS
TCBI TEXAS CAPITAL BANCSHARES INC.
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
MCY MERCURY GENERAL CORPORATION
FLO FLOWERS FOODS INC.
CTBI COMMUNITY TRUST BANCORP INC.
BUSE FIRST BUSEY CORPORATION
PATK PATRICK INDUSTRIES INC.
VFF VILLAGE FARMS INTERNATIONAL IN
SWM SCHWEITZER-MAUDUIT INTERNATIONAL INC.
CIA CITIZENS INC. CL A
BDL FLANIGAN'S ENTERPRISES INC.
CC CHEMOURS CO.
NHF NEXPOINT CREDIT STRATEGIES FUN
IOVA IOVANCE BIOTHERAPEUTICS INC
RSSS RESEARCH SOLUTIONS
RFL RAFAEL HOLDINGS CL B
BBDC BARINGS BDC INC.
YMAB Y-MABS THERAPEUTICS
REZI RESIDEO TECHNOLOGIES
IMUX INC.
FNWB IMMUNIC INC
XRX FIRST NORTHWEST BANCORP
AMPY XEROX HOLDINGS CORPORATION
VLA AMPLIFY ENERGY
TSHA ARBOR METALS
INNV TAYSHA GENE THERAPIES
SMMT INNOVAGE HOLDING
AFBI SUMMIT THERAPEUTICS INC
COOK AFFINITY BANCSHARES
TYRA INC.
BHRB TRAEGER
DPG INC.
VFC TYRA BIOSCIENCES INC
UHG BURKE & HERBERT BANK & TR/VA
GENK DUFF & PHELPS GLOBAL UTIL INCOME FD
SRBK VF CORPORATION
NKGN UNITED HOMES GROUP INC
NCDL GEN RESTAURANT GROUP INC
SDHY SR BANCORP INC
NEO NKGEN BIOTECH INC
JEQ NUVEEN CHURCHILL DIRECT LENDING CORP
LION PGIM SHORT DURATION HIGH YIELD OPPORTUNITIES FUND
SLS NEO CORPORATE PUBLIC COMPANY LIMITED
ABL THE JAPAN EQUITY FUND
INC.
LIONSGATE STUDIOS CORP
SELLAS LIFE SCIENCES GROUP INC
ABACUS GLOBAL MANAGEMENT INC.
Chemours Co: 1 director
A director at Chemours Co bought 21,222 shares at 9.489USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
- Jonathan Moreland
TCBI TEXAS CAPITAL BANCSHARES INC.
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
MMLP MARTIN MIDSTREAM PARTNERS L.P.
JRVR JAMES RIVER GROUP HOLDINGS LTD
BUSE FIRST BUSEY CORPORATION
PATK PATRICK INDUSTRIES INC.
CC CHEMOURS CO.
IMUX IMMUNIC INC
BIGC BIGCOMMERCE HOLDINGS
ADV INC.
STGW ADVANTAGE SOLUTIONS INC (A)
GRNT STAGWELL INC
SRBK GRANITE RIDGE RESOURCES INC
SR BANCORP INC
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of The Chemours Company and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 27 May 2025 in which we reassessed the appropriateness of the ratings in the context o...
Moody's Ratings assigns B1 rating to Chemours new unsecured notes; out...
Moody's Ratings (Moody's) assigned a B1 rating to The Chemours Company's ("Chemours") new senior unsecured notes due 2033. Proceeds from the notes will be used for general corporate purposes including the redemption of €441 million of senior unsecured notes maturing in May 2026. The outlook is stabl...
Moody's Ratings confirms Chemours' Ba3 CFR and other debt ratings; out...
Moody's Ratings (Moody's) confirmed The Chemours Company's ("Chemours") Ba3 Corporate Family Rating ("CFR"), Ba3-PD Probability of Default Rating ("PDR"), Ba1 rating on its senior secured bank credit facilities, and the B1 rating on its senior unsecured notes. The speculative grade liquidity rating ...
Moody's Ratings has changed DuPont's outlook to negative from stable
Moody's Ratings (Moody's) has changed DuPont de Nemours, Inc.'s ("DuPont") outlook to negative from stable, following the announcement of a proposed separation of its businesses into three distinct publicly traded companies. At the same time, Moody's has affirmed DuPont's Baa1 long term Issuer Ratin...
Moody's announces completion of a periodic review of ratings of DuPont...
Moody's Ratings has completed a periodic review of the ratings of DuPont de Nemours, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 1 April 2024 in which Moody's reassessed the appropriateness of the ratings in the context of...
Moody's places Chemours' ratings under review for downgrade
Moody's Investors Service (Moody's) has placed under review for downgrade The Chemours Company's ("Chemours") Ba3 corporate family rating ("CFR"), Ba3-PD probability of default rating ("PDR"), Ba1 rating on its senior secured credit facilities, and the B1 rating on its senior unsecured notes. Previo...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
SBH SALLY BEAUTY HOLDINGS INC.
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
LMNR LIMONEIRA CO.
AMWD CARTHAGE CEMENT
CC AMERICAN WOODMARK CORPORATION
PAGS CHEMOURS CO.
GLOB PAGSEGURO DIGITAL LTD
LYFT GAZIT-GLOBE LTD.
VIACA LYFT
JOBY VIACOMCBS INC
METBV JOBY AVIATION INC
QUICKTOU RAMACO RESOURCES INC.
QUICKTOUCH TECHNOLOGIES LTD.
- Valens Research
CC - Valens Credit Report - 2023 11 20
Credit markets are grossly overstating CC's credit risk with a YTW of 9.084% relative to an Intrinsic YTW of 6.454%, while CDS markets are materially overstating credit risk with a CDS of 355bps relative to an Intrinsic CDS of 180bps. Furthermore, Moody's is overstating the company's fundamental credit risk, with its speculative Ba3 credit rating three notches lower than Valens' XO (Baa3) credit rating. Incentives Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's...
- Valens Research
- Valens Research
CC - Valens Credit Report - 2023 08 14
Credit markets are materially overstating CC's credit risk with a YTW of 7.737% relative to an Intrinsic YTW of 5.716%, while CDS markets are overstating credit risk with a CDS of 255bps relative to an Intrinsic CDS of 157bps. Furthermore, Moody's is overstating the company's fundamental credit risk, with it speculative Ba3 credit rating three notches lower than Valens' XO (Baa3) credit rating. Incentives Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's compensa...
Moody's assigns Ba1 to Chemours' term loans; outlook stable
Moody's Investors Service (Moody's) has assigned a Ba1 rating to The Chemours Company's ("Chemours") upsized and amended and extended $960 million Senior Secured Term Loan B3 due 2028 and €515 million Senior Secured Term Loan B3 due 2028. Proceeds from the issuance will be used to repay Chemours' ex...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.